p. 187), recent research shows that celery contains high levels of the bioflavonoid apigenin which inhibits cancer growth by reducing the amount of a specific enzyme
used by cancer cells.
Ketones, on the other hand, can't be
used by cancer cells as an energy source.
Cancer Research UK scientists have discovered a new line of defence
used by cancer cells to evade cell death, according to research published in Nature Communications.
«Scientists pinpoint a new line of defense
used by cancer cells.»
The PKCƐ signal pathway, which is
used by cancer cells but rarely by normal cells, could be important in targeting some cancer cells as they rely on this pathway to survive.
Targeting stromal cells as well as the cancer cells blocks multiple cell signalling pathways that are
used by cancer cells to become aggressive.
Excess aminos — typically the end result of metabolic processes stimulated by the stress - induced release of adrenal hormones — will be available for
use by cancer cells].
Not exact matches
Chicago, GenomeWeb — A new study
by researchers from Memorial Sloan Kettering
Cancer Center has demonstrated the predictive power of an AR - V7 protein expression test using Epic Sciences» non-EPCAM-based circulating tumor cell detection platform, which could help guide treatment decisions for men with metastatic castration - resistant prostate c
Cancer Center has demonstrated the predictive power of an AR - V7 protein expression test
using Epic Sciences» non-EPCAM-based circulating tumor
cell detection platform, which could help guide treatment decisions for men with metastatic castration - resistant prostate
cancercancer.
Currently marketed for research
use by Biofluidica, the test's microfluidic channels
use specific
cancer antibodies to detect capture circulating tumor
cells.
TruePrime LB addresses current liquid biopsy sensitivity and specificity issues
by using adapted amplification of
cancer - specific, large - fragment,
cell - free DNA based on primer - free technology that combines the enzymes TthPrimPol and Phi29 DNA polymerase.
«
Used in
cancer therapy, this process could increase the impact of a treatment
by heating the
cancer cells while introducing the drug compound into the tumor.»
The compound (right panel) has a scorpion - like shape with two arms grabbing EphA2 - expressing
cancer cells, and a tail (brown) constituted
by a cytotoxic chemotherapeutic agent (paclitaxel
used in this work).
A route
used by tumor
cells to spread could be exploited to make stem
cells for regenerative medicine and
cancer therapies
Doxorubicin is a chemotherapy drug
used to treat a wide range of
cancers by preventing
cancer cells from replicating.
Inspired
by his own bout of leukemia to try to find a better
cancer treatment, retired broadcasting station owner Kanzius guessed that as an alternative to chemotherapy, he could inject tumors with metal ions, then
use radio waves to heat the metal and destroy cancerous
cells.
«Overall, our studies show that
by using modified techniques we will be able to observe non-uniform
cancer cells, regardless of their origin,» Polo - Parada said.
Dr Claudia Wellbrock, study author and
Cancer Research UK scientist at The University of Manchester and a member of the Manchester Cancer Research Centre, said: «We used to think that cancer cells spread by first specialising in invading other parts of the body and then change in order to grow ra
Cancer Research UK scientist at The University of Manchester and a member of the Manchester
Cancer Research Centre, said: «We used to think that cancer cells spread by first specialising in invading other parts of the body and then change in order to grow ra
Cancer Research Centre, said: «We
used to think that
cancer cells spread by first specialising in invading other parts of the body and then change in order to grow ra
cancer cells spread
by first specialising in invading other parts of the body and then change in order to grow rapidly.
The
cancer cell does so
by forming short - lived invadopodia — foot - like protrusions these
cells use to invade.
The
use of proteasome inhibitors to treat
cancer has been greatly limited
by the ability of
cancer cells to develop resistance to these drugs.
Chinnaiyan and colleagues then conducted studies
using cancer cells and found that the different FGFR fusion proteins all seemed to drive
cancer cell proliferation
by activating FGFR signaling.
«Mechanisms
cancer cells use to establish metastatic brain tumors revealed
by research.»
A «Trojan horse» treatment for an aggressive form of brain
cancer, which involves
using tiny nanoparticles of gold to kill tumour
cells, has been successfully tested
by scientists.
«If you give patients immune
cells to eradicate any remaining
cancer cells that might be present,» he says, «those immune
cells would not be prevented from doing their job
by ongoing immune suppression drugs that are being
used in patients treated with conventional transplant approaches.»
Developed
by Amgen, it
uses a modified version of the herpes virus that can't infect healthy tissue but attacks
cancer cells.
Now, in a new study
using laboratory - grown
cells and mice, Johns Hopkins scientists report that a method they
used to track metabolic pathways heavily favored
by cancer cells provides scientific evidence for combining anti-
cancer drugs, including one in a nanoparticle format developed at Johns Hopkins, that specifically target those pathways.
But their overriding interest in BPTES, says Slusher, was in how it works:
by blocking the production of glutamine, an amino acid that acts as a building block of
cells and is
used frequently
by pancreatic
cancers to create more
cancer cells.
By using «gemcitabine» chemotherapy to target
cancer cells, and a form of vitamin A to target the surrounding stromal
cells, the combined approach led to a reduction in
cancer cell proliferation and invasion.
«This could be useful in developing new combination therapies, where multiple drugs are
used simultaneously to treat a
cancer by attacking different parts of the
cancer cells at the same time.»
Using the same computer - based approach, the team has now been able to target the c - FLIP (cellular FLICE [FADD - like IL - 1β - converting enzyme]- inhibitory) protein, known to play a key role in
cancer stem
cell maintenance and survival, described in previously published work
by the Institute.
Treatment for advanced melanoma has seen success with targeted therapies — drugs that interfere with division and growth of
cancer cells by targeting key molecules — especially when multiple drugs are
used in combination.
Qingdong Zheng, a materials scientist at John Hopkins University in Baltimore, Maryland, suggests that such biolasers could find
uses in new types of sensors or in light - based therapeutics, in which light is
used, for example, to kill
cancer cells by triggering drugs into action that have already been administered.
Autophagy has emerged as a key pathway that
cancer cells use to survive in the face of assault
by chemotherapy and radiation; however, autophagy as a potential druggable mechanism in patients who become resistant to BRAF inhibitors has not been investigated.
To see whether
cancer stem
cell renewal involves a chain of events similar to that
used by embryonic stem
cells, and whether the process was affected
by oxygen levels, Semenza and graduate student Chuanzhao Zhang focused their studies on two human breast
cancer cell lines that responded to low oxygen
by ramping up production of the protein ALKBH5, which removes methyl groups from mRNAs.
This widespread lack of the need for telomerase is
used by evolution as a key component of our defense against
cancer, because having a limit to the size and renewal of telomeres prevents our
cells from replicating themselves indefinitely — the crucial hallmark of
cancer.
Saatchi, which is owned
by France's Publicis Groupe, SA, chose LifeStraw over a field of competitors that included a reusable controller to improve the distribution of IV fluids, a collapsible wheel that can be folded down for easier storage when not in
use on bicycles or wheelchairs, an energy - efficient laptop designed for children in developing countries, a 3 - D display that
uses special optics and software to project a hologramlike image of patient anatomy for
cancer treatment, an inkjet printing system for fabricating tissue scaffolds on which
cells can be grown, a visual prosthesis for bypassing a diseased or damaged eye and sending signals directly to the brain, books with embedded sound tracks to help educate illiterate adults on health issues, a phone that provides telecommunications coverage to poor rural populations in developing countries, and a brain - computer interface designed to help paralyzed people communicate via neural signals.
Slusher teamed up with Johns Hopkins Kimmel
Cancer Center immunologist Jonathan Powell, M.D., Ph.D., who has studied how cancer cells use different metabolic pathways to evade destruction by immune
Cancer Center immunologist Jonathan Powell, M.D., Ph.D., who has studied how
cancer cells use different metabolic pathways to evade destruction by immune
cancer cells use different metabolic pathways to evade destruction
by immune
cells.
Our new findings tell us that low oxygen conditions actually encourage certain
cancer stem
cells to multiply through the same mechanism
used by embryonic stem
cells.»
Cancer cells survived longer
by using the UPR to suppress Bmal1 and short - circuit their circadian rhythms.
However, the
use of NF - kB inhibitors in treating
cancer is complicated
by severe side effects related to immunosuppression caused
by indiscriminate inhibition of NF - kB in normal immune
cells.
«We hope that
by using these computational approaches to understanding
cancer cell systems, we've widened the field for finding the new desperately needed
cancer drugs,» said Dr Módos.
The proposed clinical trial, in which researchers would
use CRISPR to engineer immune
cells to fight
cancer, won approval from the Recombinant DNA Advisory Committee (RAC) at the U.S. National Institutes of Health, a panel that has traditionally vetted the safety and ethics of gene therapy trials funded
by the U.S. government and others.
Aware that
cancers rewire their metabolism in ways that could change the epigenome and that distant metastases in pancreatic
cancer naturally spread to organs fed
by a sugar - rich blood supply, the researchers wondered if the tumor
cells had altered the way they
use the basic form of sugar, glucose.
The researchers, who released their findings in
Cancer Prevention Research Journal, published
by the American Association of
Cancer Research,
used a visualization technique — immunofluorescence — to identify stem
cells in the colon of pigs that were fed either a high calorie diet or a standard diet.
Researchers
used IL - 15 to develop a whole tumor
cell vaccine to target breast (TS / A) and prostate (TRAMP - C2)
cancer cells in animal models; results showed that tumor
cells stopped growing after the vaccine was introduced and that beneficial effects were enhanced further when IL - 15Rα was co-produced
by the vaccine
cells.
«Obviously, this information can be
used in our efforts to identify drug therapies that kill
cancer cells by targeting telomerase activity.»
These diets may naturally be providing a shotgun approach to
cancer prevention
by using a wide variety of beneficial compounds to target multiple pathways that
cancer stem
cells use to survive.
New results from a clinical trial involving more than 900 military veterans at high risk for keratinocyte carcinoma skin
cancer provides evidence that
using the generic skin cream fluorouacil 5 percent for two to four weeks may reduce the risk of a squamous
cell carcinoma (SCC) needing surgery
by 75 percent within a year.
The researchers tested two anti-CK2 drugs for their ability to stimulate the production of new brown fat in mice: a new small - molecule CK2 - blocker called silmitasertib (CX - 4945), which is already in clinical trials as a
cancer therapeutic; and a more precise next - generation antisense oligonucleotide (ASO) drug developed in collaboration with Isis Pharmaceuticals, which eliminates CK2
by blocking the RNA instructions
cells use to produce it.
A team of researchers in Germany and Denmark led
by Steven Johnsen, Professor at the University Medical Center Göttingen, Germany,
used human prostate
cancer cell lines and depleted them of the DNA - binding protein CHD1.
By using molecular genetic tools to reduce the amount of PC in human lung
cancer cells, the team observed decreased
cell growth, a compromised ability to form colonies in soft agar (a gelatinous material specifically
used to grow bacteria and other
cells), and a reduced rate of tumor growth in mice.